Bruno Quesnel

p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignancies

Eric Wattel, Claude Preudhomme, B Hecquet et al. · Blood · 1994 · 581 citations · Full text

Medicine, Hematology, Oncology +16

Plasma cells from multiple myeloma patients express B7-H1 (PD-L1) and increase expression after stimulation with IFN-γ and TLR ligands via a MyD88-, TRAF6-, and MEK-dependent pathway

Jizhong Liu, Abdelbasset Hamrouni, Dariusz Wołowiec et al. · Blood · 2007 · 576 citations · Full text

Medicine, Hematology, Immunology +8

Luspatercept in Patients with Lower-Risk Myelodysplastic Syndromes

Pierre Fenaux, Uwe Platzbecker, Ghulam J. Mufti et al. · New England Journal of Medicine · 2020 · 537 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

A randomized phase 3 study of lenalidomide versus placebo in RBC transfusion-dependent patients with Low-/Intermediate-1-risk myelodysplastic syndromes with del5q

Pierre Fenaux, Aristoteles Giagounidis, Dominik Selleslag et al. · Blood · 2011 · 480 citations · Full text

Medicine, Hematology, Pharmacology +14

Outcome of High-Risk Myelodysplastic Syndrome After Azacitidine Treatment Failure

Thomas Prébet, Steven D. Gore, Benjamin Esterni et al. · Journal of Clinical Oncology · 2011 · 480 citations · Full text

Medicine, Hematology, Pharmacotherapy +16